BCAX · Bicara Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Open Market | 4,603,418 Shares held | 2/26/2026 | View profile |
| TPG GP A, LLC 10% Owner | ▼ Sell | Other | 1,960,425 Shares held | 9/16/2024 | View profile |
| FMR LLC | ▼ Sell | Other | 1,115,333 Shares held | 9/16/2024 | View profile |
| Biocon Ltd | ▼ Sell | Other | 1,080,775 Shares held | 9/16/2024 | View profile |
| FIL Ltd | ▼ Sell | Other | 1,013,853 Shares held | 9/16/2024 | View profile |
| James E. Flynn 10% Owner | ▲ Buy | Open Market | 897,587 Shares held | 9/17/2024 | View profile |
| Mazumdar-Shaw Kiran | ▼ Sell | Other | 432,736 Shares held | 9/16/2024 | View profile |
| Claire Mazumdar Chief Executive Officer | ▼ Sell | Open Market | 362,152 Shares held | 8/10/2026 | View profile |
| Ryan Cohlhepp President, COO & Interim CEO | ▼ Sell | Open Market | 181,641 Shares held | 9/8/2026 | View profile |
| Ivan Hyep Chief Financial Officer | ▼ Sell | Open Market | 129,855 Shares held | 8/10/2026 | View profile |
| David Raben Chief Medical Officer | ▼ Sell | Open Market | 55,286 Shares held | 4/27/2026 | View profile |
| Meisner Lara Chief Legal Officer | ▼ Sell | Open Market | 0 Shares held | 9/29/2025 | View profile |
Transaction History
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 17,500 | $66K | 9/8/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 14,058 | $320K | 9/8/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 3,442 | $81K | 9/8/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 12,500 | $47K | 8/10/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 12,500 | $350K | 8/10/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 10,000 | $38K | 8/10/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 10,000 | $280K | 8/10/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 18,750 | $71K | 8/10/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 18,750 | $525K | 8/10/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 10,000 | $38K | 7/10/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 28 | $831 | 7/10/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 9,972 | $283K | 7/10/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 536 | $16K | 7/9/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 18,750 | $71K | 7/8/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 22,833 | $657K | 7/8/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,306 | $128K | 7/8/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 1,075 | $33K | 7/8/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 12,500 | $47K | 7/8/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 22,757 | $651K | 7/8/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 4,413 | $132K | 7/8/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 830 | $25K | 7/8/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 9,200 | $35K | 5/21/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 9,200 | $188K | 5/21/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 15,000 | $57K | 5/18/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 12,022 | $240K | 5/18/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 2,978 | $61K | 5/18/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 8,000 | $30K | 5/15/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 8,000 | $162K | 5/15/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,500 | $91K | 5/15/2026 |
| David Raben | ▲ Buy | Option Exercise | 5,500 | $21K | 4/27/2026 |
| David Raben | ▼ Sell | Open Market | 5,500 | $126K | 4/27/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 9,200 | $35K | 4/21/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 9,200 | $212K | 4/21/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 15,000 | $57K | 4/20/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 15,000 | $354K | 4/20/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 8,226 | $36K | 4/16/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 7,454 | $28K | 4/16/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 7,080 | $39K | 4/16/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 8,000 | $30K | 4/15/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 8,000 | $184K | 4/15/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,500 | $104K | 4/15/2026 |
| David Raben | ▲ Buy | Option Exercise | 5,500 | $21K | 3/25/2026 |
| David Raben | ▼ Sell | Open Market | 5,500 | $104K | 3/25/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 9,200 | $35K | 3/23/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 9,200 | $170K | 3/23/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 1,596 | $6K | 3/20/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 1,596 | $30K | 3/20/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 6,905 | $26K | 3/19/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 6,905 | $130K | 3/19/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 6,499 | $25K | 3/18/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 6,499 | $122K | 3/18/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 8,000 | $157K | 3/16/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,500 | $88K | 3/16/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 8,000 | $30K | 3/16/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 36,766 | $139K | 3/9/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 36,766 | $705K | 3/9/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 3,817 | $14K | 3/6/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 3,817 | $72K | 3/6/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 1,786 | $7K | 3/5/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 1,786 | $33K | 3/5/2026 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 2,631 | $10K | 3/4/2026 |
| Claire Mazumdar | ▼ Sell | Open Market | 2,631 | $49K | 3/4/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 2,963 | $11K | 3/4/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 2,963 | $54K | 3/4/2026 |
| David Raben | ▲ Buy | Option Exercise | 16,300 | $62K | 3/4/2026 |
| David Raben | ▼ Sell | Open Market | 16,300 | $302K | 3/4/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 12,892 | $49K | 3/3/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 12,892 | $234K | 3/3/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,500 | $82K | 3/3/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 7,318 | $28K | 3/3/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 6,237 | $24K | 3/3/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 13,555 | $247K | 3/3/2026 |
| David Raben | ▲ Buy | Option Exercise | 200 | $758 | 3/3/2026 |
| David Raben | ▼ Sell | Open Market | 200 | $4K | 3/3/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 300,000 | $4.8M | 2/26/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 3,108 | $12K | 2/25/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 3,108 | $56K | 2/25/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 523 | $9K | 2/25/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 3,828 | $69K | 1/22/2026 |
| Ivan Hyep | ▲ Buy | Option Exercise | 1,882 | $7K | 1/22/2026 |
| Ivan Hyep | ▼ Sell | Open Market | 1,882 | $34K | 1/22/2026 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 149 | $3K | 1/15/2026 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 25,000 | $111K | 12/26/2025 |
| David Raben | ▲ Buy | Option Exercise | 19,789 | $75K | 12/26/2025 |
| Ivan Hyep | ▲ Buy | Option Exercise | 9,200 | $35K | 12/22/2025 |
| Ivan Hyep | ▼ Sell | Open Market | 9,200 | $168K | 12/22/2025 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 29,500 | $161K | 12/16/2025 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 8,000 | $30K | 12/15/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 8,000 | $149K | 12/15/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,500 | $84K | 12/15/2025 |
| David Raben | ▲ Buy | Option Exercise | 4,594 | $17K | 11/25/2025 |
| David Raben | ▼ Sell | Open Market | 4,594 | $87K | 11/25/2025 |
| David Raben | ▲ Buy | Option Exercise | 906 | $3K | 11/25/2025 |
| David Raben | ▼ Sell | Open Market | 906 | $17K | 11/25/2025 |
| Ivan Hyep | ▲ Buy | Option Exercise | 17,795 | $67K | 11/24/2025 |
| Ivan Hyep | ▼ Sell | Open Market | 17,795 | $330K | 11/24/2025 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 41,163 | $156K | 11/24/2025 |
| Claire Mazumdar | ▼ Sell | Open Market | 41,163 | $776K | 11/24/2025 |
| David Raben | ▲ Buy | Option Exercise | 5,500 | $21K | 11/24/2025 |
| David Raben | ▼ Sell | Open Market | 5,500 | $101K | 11/24/2025 |
| Ivan Hyep | ▲ Buy | Option Exercise | 605 | $2K | 11/21/2025 |
| Ivan Hyep | ▼ Sell | Open Market | 605 | $11K | 11/21/2025 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 8,000 | $30K | 11/21/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 8,000 | $144K | 11/21/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,500 | $81K | 11/21/2025 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 24,103 | $91K | 10/16/2025 |
| Claire Mazumdar | ▼ Sell | Open Market | 24,103 | $454K | 10/16/2025 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 13,289 | $50K | 10/15/2025 |
| Claire Mazumdar | ▼ Sell | Open Market | 13,289 | $250K | 10/15/2025 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 8,000 | $30K | 10/15/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 8,000 | $145K | 10/15/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 4,500 | $82K | 10/15/2025 |
| Claire Mazumdar | ▲ Buy | Option Exercise | 11,445 | $43K | 10/13/2025 |
| Claire Mazumdar | ▼ Sell | Open Market | 11,445 | $217K | 10/13/2025 |
| David Raben | ▲ Buy | Option Exercise | 22,000 | $83K | 10/9/2025 |
| Ivan Hyep | ▲ Buy | Option Exercise | 6,415 | $24K | 10/9/2025 |
| Ivan Hyep | ▼ Sell | Open Market | 6,415 | $117K | 10/9/2025 |
| David Raben | ▼ Sell | Open Market | 22,000 | $406K | 10/9/2025 |
| Ivan Hyep | ▲ Buy | Option Exercise | 5,627 | $21K | 10/8/2025 |
| Ivan Hyep | ▼ Sell | Open Market | 5,627 | $102K | 10/8/2025 |
| Ivan Hyep | ▲ Buy | Option Exercise | 18,244 | $69K | 10/7/2025 |
| Ivan Hyep | ▼ Sell | Open Market | 18,244 | $332K | 10/7/2025 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 8,000 | $30K | 10/7/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 8,000 | $144K | 10/7/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 2,900 | $52K | 10/7/2025 |
| Ivan Hyep | ▲ Buy | Option Exercise | 6,514 | $25K | 10/6/2025 |
| Ryan Cohlhepp | ▲ Buy | Option Exercise | 24,000 | $91K | 10/6/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 24,000 | $433K | 10/6/2025 |
| Ryan Cohlhepp | ▼ Sell | Open Market | 15,600 | $282K | 10/6/2025 |
| Ivan Hyep | ▼ Sell | Open Market | 6,514 | $118K | 10/6/2025 |
| Meisner Lara | ▲ Buy | Option Exercise | 33,807 | $312K | 9/29/2025 |
| Meisner Lara | ▼ Sell | Open Market | 33,807 | $499K | 9/29/2025 |
| Meisner Lara | ▼ Sell | Open Market | 15,829 | $182K | 9/15/2025 |
| Meisner Lara | ▲ Buy | Option Exercise | 15,829 | $86K | 9/15/2025 |
| Meisner Lara | ▲ Buy | Option Exercise | 15,829 | $86K | 6/16/2025 |
| Meisner Lara | ▼ Sell | Open Market | 15,829 | $165K | 6/16/2025 |
| Meisner Lara | ▲ Buy | Option Exercise | 79,146 | $431K | 3/14/2025 |
| Meisner Lara | ▼ Sell | Open Market | 48,526 | $616K | 3/14/2025 |
| Meisner Lara | ▼ Sell | Open Market | 30,620 | $406K | 3/14/2025 |
| James E. Flynn | ▼ Sell | Other | 862,587 | — | 9/17/2024 |
| James E. Flynn | ▼ Sell | Other | 862,587 | — | 9/17/2024 |
| James E. Flynn | ▲ Buy | Open Market | 35,000 | $630K | 9/17/2024 |
| James E. Flynn | ▲ Buy | Open Market | 35,000 | $630K | 9/17/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 1,680,520 | $30.2M | 9/16/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 152,480 | $2.7M | 9/16/2024 |
| TPG GP A, LLC | ▼ Sell | Other | 1,960,425 | — | 9/16/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 2,500,095 | — | 9/16/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 2,622,898 | — | 9/16/2024 |
| FIL Ltd | ▼ Sell | Other | 54,092 | — | 9/16/2024 |
| FIL Ltd | ▼ Sell | Other | 352,876 | — | 9/16/2024 |
| FMR LLC | ▼ Sell | Other | 10,818 | — | 9/16/2024 |
| FMR LLC | ▼ Sell | Other | 712,430 | — | 9/16/2024 |
| FMR LLC | ▼ Sell | Other | 392,085 | — | 9/16/2024 |
| Biocon Ltd | ▼ Sell | Other | 4,327,365 | $0 | 9/16/2024 |
| Biocon Ltd | ▼ Sell | Other | 1,080,775 | $0 | 9/16/2024 |
| Mazumdar-Shaw Kiran | ▼ Sell | Other | 4,327,365 | $0 | 9/16/2024 |
| Mazumdar-Shaw Kiran | ▼ Sell | Other | 1,080,775 | $0 | 9/16/2024 |
| Mazumdar-Shaw Kiran | ▼ Sell | Other | 324,552 | $0 | 9/16/2024 |
| Mazumdar-Shaw Kiran | ▼ Sell | Other | 432,736 | $0 | 9/16/2024 |
| FIL Ltd | ▼ Sell | Other | 606,885 | — | 9/16/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
BCAX flagged as potentially overvalued on book value
A recent analysis suggests Bicara Therapeutics stock may be overvalued when compared to its book value. This valuation concern is notable given that the stock is currently trading near its 52-week low and has an RSI of 30.1, indicating it is in oversold territory. While the average analyst target is $35.50, the wide range of estimates reflects significant uncertainty about the company's future performance.
BCAX flagged as potentially overvalued on book value. A recent analysis suggests Bicara Therapeutics stock may be overvalued when compared to its book value. This valuation concern is notable given that the stock is currently trading near its 52-week low and has an RSI of 30.1, indicating it is in oversold territory. While the average analyst target is $35.50, the wide range of estimates reflects significant uncertainty about the company's future performance.